
Sign up to save your podcasts
Or
Dr. Jason Crowell talks with Dr. Elsmarieke van de Giessen and Emma Coomans about a newly FDA-approved tau-binding radiotracer [18F]flortaucipir and an accompanying visual read method to support the diagnostic process in cognitively impaired patients assessed for Alzheimer disease.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
4.7
279279 ratings
Dr. Jason Crowell talks with Dr. Elsmarieke van de Giessen and Emma Coomans about a newly FDA-approved tau-binding radiotracer [18F]flortaucipir and an accompanying visual read method to support the diagnostic process in cognitively impaired patients assessed for Alzheimer disease.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
135 Listeners
315 Listeners
47 Listeners
496 Listeners
3,321 Listeners
90 Listeners
1,109 Listeners
24 Listeners
194 Listeners
517 Listeners
132 Listeners
350 Listeners
182 Listeners
366 Listeners
78 Listeners